OJSCY yields 68.19% · PFE yields 6.13%● Live data
📍 OJSCY pulled ahead of the other in Year 1
Combined, OJSCY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OJSCY + PFE for your $10,000?
Public Joint Stock Company Rosneft Oil Company, together with its subsidiaries, engages in the exploration, development, production, and sale of crude oil and gas. It operates in two segments, Exploration and Production; and Refining and Distribution. The company produces liquid hydrocarbons in Western and Eastern Siberia, Timan-Pechora, Ural-Volga, Southern part of European Russia, and the Russian Far East. It is also involved in producing petrochemicals products; base and industrial oils; motor and transmission oils for cars and trucks, buses, agricultural and special equipment, and railway and marine transport; special oils for the aviation industry; hydraulic, gear, turbine, compressor, transformer oils, etc.; coolants, softener oils, paraffins, etc.; and additives to fuels and oils. In addition, the company transports and exports crude oil through pipelines, and railway and mixed transportation; sells petrochemicals and liquefied petroleum gas, which include phenolic chain, aromatics, polymers, olefins, alcohols, oil refinement, fuel material, and other petrochemical products; and provides bunkering and aircraft refueling services, as well as bitumen products. Further, it operates a network of filling stations. The company was founded in 1995 and is based in Moscow, Russia. Public Joint Stock Company Rosneft Oil Company operates as a subsidiary of OJSC Rosneftegaz.
Full OJSCY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.